Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Short-term Investments (2023 - 2025)

Orthofix Medical (OFIX) has disclosed Short-term Investments for 5 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments rose 23.6% year-over-year to $3.1 million, compared with a TTM value of $3.1 million through Dec 2025, up 23.6%, and an annual FY2025 reading of $3.1 million, up 23.6% over the prior year.
  • Short-term Investments was $3.1 million for Q4 2025 at Orthofix Medical, roughly flat from $3.1 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $4.6 million in Q4 2023 and bottomed at $2.5 million in Q1 2024.
  • Average Short-term Investments over 3 years is $2.9 million, with a median of $2.5 million recorded in 2024.
  • The sharpest move saw Short-term Investments crashed 46.24% in 2024, then increased 23.6% in 2025.
  • Year by year, Short-term Investments stood at $4.6 million in 2023, then tumbled by 46.24% to $2.5 million in 2024, then rose by 23.6% to $3.1 million in 2025.
  • Business Quant data shows Short-term Investments for OFIX at $3.1 million in Q4 2025, $3.1 million in Q3 2025, and $3.1 million in Q2 2025.